Literature DB >> 7819350

Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population.

H U Wagner1, E Van Dyck, E Roggen, A J Nunn, A Kamali, D S Schmid, J G Dobbins, D W Mulder.   

Abstract

The aim of the study was to determine in a rural population the age- and sex-specific prevalence and incidence rates of serological reactivity of 5 common sexually transmitted diseases (STDs) and their association with HIV-1 antibody status. Of the adult population of two villages (529 adults aged 15 years or more) 294 provided an adequate blood specimen both on enrollment and at 12 months. The sera were tested at 3 collaborating laboratories for antibodies against HIV-1, Treponema pallidum, Haemophilus ducreyi, Chlamydia trachomatis and herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). A sample of 45 children were tested for HSV-1 and HSV-2. Seroprevalence rates in adults on enrollment were 7.8% for HIV-1, 10.8% for active syphilis, 10.4% for H. ducreyi, 66.0% for C. trachomatis, 91.2% for HSV-1 and 67.9% for HSV-2. Males were significantly more likely than females to be seropositive for H. ducreyi (15.6% versus 6.6%), but less likely to be HSV-2 antibody positive (57.0% versus 74.4%). Reactivity to H. ducreyi, C. trachomatis and HSV-2 rose with increasing age. In contrast, active syphilis showed no age trend. All STDs tended to be more common in those HIV-1 seropositive. Incidence rates over the 12 months were nil for HIV-1, 0.5% for syphilis, 1.2% for H. ducreyi, 11.3% for C. trachomatis, and 16.7% for HSV-2. The results of this exploratory study indicate that all STDs included are common in this rural population. The high HSV-2 prevalence rate among adolescents suggests that HSV-2 may be an important risk factor for HIV-1 infection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Chlamydia; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Herpes Genitalis; Hiv Infections; Incidence; Infections; Measurement; Population; Population Characteristics; Prevalence; Reproductive Tract Infections; Research Methodology; Rural Population; Sampling Studies; Sex Factors; Sexually Transmitted Diseases; Studies; Surveys; Syphilis; Uganda; Viral Diseases

Mesh:

Year:  1994        PMID: 7819350     DOI: 10.1177/095646249400500509

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  21 in total

1.  Seroprevalence of HIV, hepatitis B, and syphilis in an urban population and isolated villages in Gabon.

Authors:  E Bertherat; R Nabias; M C Georges-Courbot; A Renaut
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

2.  Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda.

Authors:  Edith Nakku-Joloba; Fred Kambugu; Julius Wasubire; Joshua Kimeze; Robert Salata; Jeffrey M Albert; Alfred Rimm; Christopher Whalen
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

3.  Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Authors:  Jordyn L Gamiel; Aaron A R Tobian; Oliver B Laeyendecker; Steven J Reynolds; Rhoda Ashley Morrow; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

4.  Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2.

Authors:  D S Schmid; D R Brown; R Nisenbaum; R L Burke; D Alexander; R Ashley; P E Pellett; W C Reeves
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 5.  Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group.

Authors:  R Hayes; M Wawer; R Gray; J Whitworth; H Grosskurth; D Mabey
Journal:  Genitourin Med       Date:  1997-12

6.  Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.

Authors:  Ramzi A Alsallaq; Joshua T Schiffer; Ira M Longini; Anna Wald; Lawrence Corey; Laith J Abu-Raddad
Journal:  Sex Transm Dis       Date:  2010-05       Impact factor: 2.830

7.  Decreasing HIV-1 seroprevalence in young adults in a rural Ugandan cohort.

Authors:  D Mulder; A Nunn; A Kamali; J Kengeya-Kayondo
Journal:  BMJ       Date:  1995-09-30

8.  Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population.

Authors:  A Kamali; A J Nunn; D W Mulder; E Van Dyck; J G Dobbins; J A Whitworth
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

9.  Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992-1993. The Pregnancy and HIV (EGE) Group.

Authors:  V Leroy; A De Clercq; J Ladner; J Bogaerts; P Van de Perre; F Dabis
Journal:  Genitourin Med       Date:  1995-08

10.  The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth.

Authors:  Marshall W Munjoma; Edith N Kurewa; Munyaradzi P Mapingure; Grace V Mashavave; Mike Z Chirenje; Simbarashe Rusakaniko; Akhtar Hussain; Babill Stray-Pedersen
Journal:  BMC Womens Health       Date:  2010-01-12       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.